Search

Washington, DC's Premier I71 Compliant Art Gallery. At the Metropolitan Art & Sculpture Collaboration you can discover the beautiful works our artists currently have on show as well as all the wonderful gifts we have available. We work hard to surprise and innovate, designing and redesigning our space to carefully compliment our artists’ work and making sure our customers have highly enjoyable gifting experiences. MASC WEBSITE MENU REVIEWS 1528 U St. Washington, DC, 20009 United States (202) 290-9596 Washington, DC's Premier I71 Compliant Art Gallery! At the Metropolitan Art & Sculpture Collaboration you can discover the beautiful works our artists currently have on show as well as all the wonderful gifts we have available. We work hard to surprise and innovate, designing and redesigning our space to carefully compliment our artists’ work and making sure our customers have highly enjoyable gifting experiences. Hours: Mon-Sat 12-8pm, Sun 12-6pm MASC Reviews Recent Reviews Sodalicious - MASC Here's another batch of exotic designer flower from DC i-71 marijuana dispensary, MASC. This time it's the Sodalicious strain and the nam... Toker's Guide Sep 28, 2023 1 min read Basqui Gumbo - MASC The latest and greatest offering from DC i-71 marijuana dispensary, MASC, is the Basqui Gumbo Strain. These buds immediately caught my ey... Terp Interpreter Sep 7, 2023 1 min read Sriracha Fumi - MASC Get ready to heat things up with this Sriracha Fumi strain available now at DC i-71 marijuana dispensary, MASC. Just like a splash of Sri... Terp Interpreter Aug 17, 2023 1 min read Donut Runtz - MASC With a fun looking pack and a sweet aroma this batch of Donut Runtz from DC i-71 storefront dispensary, MASC, is ready to help you get yo... Toker's Guide Jul 21, 2023 2 min read Happy Dab Day! Here Are Five Dab-Worthy Concentrates in DC Right Now Why is July 10th known as Dab Day, you might ask? It's quite simple really. If you turn 710 around and upside down it spells "OIL" and th... Toker's Guide Jul 10, 2023 4 min read Italian Ice - MASC Take a look at this Italian Ice from DC Art Gallery and i-71 storefront dispensary, MASC. I remember being a kid and getting so excited w... Terp Interpreter Jun 30, 2023 2 min read Blue Gushers - MASC If you haven't checked out DC i-71 cannabis dispensary, MASC, now is a great time to stop on by. There've got this delectable batch of ex... Toker's Guide Jun 21, 2023 1 min read Lemon Poppers - MASC This batch of Lemon Poppers from DC i-71 storefront, MASC, is a deliciously cheesy, sour citrus smelling varietal that will pick you up... Elle Weeds May 11, 2023 1 min read Pine Zol - MASC With a nose similar to Lemon Cherry Gelato, but with more piney elements, this batch of Pine Zol from DC i-71 storefront dispensary, MASC... Toker's Guide Apr 29, 2023 1 min read Wonderland Watermelon Infused Vegan Gummies - MASC These Wonderland Watermelon Gummies are just what I needed this week! This is because my throat had been itchy and scratchy all thanks... Ben from Kannabus Feb 28, 2023 2 min read Cream - MASC This Cream from DC i-71 storefront MASC (Metropolitan Art & Sculpture Collaboration) has a remarkably creamy aroma and is a super smooth ... Elle Weeds Feb 4, 2023 1 min read Motordrip by Magnolia Pharms - MASC After the wonderful experience I had with the Magnolia Pharms DS11 recently I was stoked to see more of their jars at DC recreational... Toker's Guide Dec 17, 2022 2 min read DS11 by Magnolia Pharms - MASC The jar comes with an outer cellophane wrap as well as an internal seal, so you know this one is still fresh and ready to rock. Even... Toker's Guide Nov 29, 2022 2 min read Super Lemon Cherry Gelato by The Wizard of Za - MASC The first thing I noticed about this batch of Super Lemon Cherry from DC recreational (i-71) storefront MASC was how downright pretty it... Sophie Oct 7, 2022 2 min read Georgetown Pressure by Terp Lords & The Wizard of Za - MASC According to the Urban Dictionary "pressure" is "that bomb ass weed" or "weed that will make you suffocate". After taking a peek at this... Toker's Guide Sep 23, 2022 2 min read Terpadelic - MASC Back for another strain review and this time, I’m smoking on some chronic nugs cultivated by Terplords and available from DC recreational... Ben from Kannabus Aug 11, 2022 3 min read Rock Creek Fruit Punch - MASC If you're not familiar with the Metropolitan Art and Sculpture Collaboration, or MASC for short, they're a DC recreational (i-71)... Toker's Guide Jul 26, 2022 2 min read

Virginia senators advanced a bill to legalize and regulate recreational marijuana sales, which passed the Senate Rehabilitation & Social Services Committee and is now heading to the Senate Courts of Justice Committee. The legislation, which has the support of the new Governor Abigail Spanberger, aims to establish a commercial market by January 1, 2027, and includes details on taxation, purchase limits, THC caps, and the creation of the Virginia Cannabis Control Authority. < Back Virginia Senators Approve Bill To Legalize Marijuana Sales Under New Pro-Reform Governor Jan 23, 2026 Kyle Jaeger Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Virginia senators have advanced a bill to legalize and regulate recreational marijuana sales—one of several reform proposals under consideration as the 2026 session gets underway. The Senate Rehabilitation & Social Services Committee on Friday took up two marijuana sales legalization measures. After amending one of the proposals from Sen. Lashrecse Aird (D) with a substitute version, it passed the panel in a 8-7 vote. The bill largely aligns with recommendations released last month by the legislature’s Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market. Since legalizing cannabis possession and home cultivation in 2021, Virginia lawmakers have worked to establish a commercial marijuana market—only to have those efforts consistently stalled under former Gov. Glenn Youngkin (R), who twice vetoed measures to enact it that were sent to his desk by the legislature. “In 2021 Virginia became the first southern state to legalize adult use cannabis, and five years later, Virginia has yet to implement the marketplace we originally envisioned,” Aird said on Friday. “Each year that we go without a marketplace, the illicit market grows and health and safety concerns rise for our citizens.” “The legislation establishes a market, once and for all, that will protect consumers, protect health and safety while ensuring balance by creating a market that takes into account the harms created by the disproportionate enforcement of cannabis laws felt by Black and brown communities,” she said. Under the measure as revised by the committee, adult-use cannabis sales could begin on January 1, 2027. The Senate committee also considered a separate cannabis sales measure sponsored by Sen. Aaron Rouse (D), and incorporated it into Aird’s bill, which will be the main vehicle for the reform this session. The overall legislation, which next heads to the Senate Courts of Justice Committee, will help to “ensure our communities are safe,” Rouse told the committee on Friday. “In recent years we’ve seen an unchecked proliferation of illegal and unregulated marijuana stores,” he said. “This has put Virginias at risk as unlicensed drug dealers sells billions of dollars of untested and untaxed products, frequently to children. A well-regulated marijuana retail market is a necessity for public safety and would ensure that products are tested for safety, that they are accurately labeled, sold in a controlled environment and kept away from kids.” On the House side, members of the General Laws Subcommittee are also slated to hold a hearing on Friday afternoon on a marijuana sales legalization bill from Del. Paul Krizek (D), who chaired the joint commission that produced the regulatory recommendations. That legislation mirrors Aird’s own bill as filed prior to being amended. *Here are the key details of the Virginia marijuana sales legalization legislation:* - Retail sales could begin on January 1, 2027. - Adults would be able to purchase up to 2.5 ounces of marijuana in a single transaction, or up to an equivalent amount of other cannabis products as determined by regulators. - The Virginia Cannabis Control Authority would oversee licensing and regulation of the new industry. Its board of directors would have the authority to control possession, sale, transportation, distribution, delivery and testing of marijuana. - A tax of up to 11.625 percent would apply to the retail sale of any cannabis product. That would include a state retail and use tax of 1.125 percent on top of a new marijuana-specific tax of 8 percent. Local governments could levy an additional 3.5 percent. - Tax revenue would be split between the costs of administering and enforcing the state’s marijuana system, a new Cannabis Equity Reinvestment Fund, pre-kindergarten programs, substance use disorder prevention and treatment programs and public health programs such as awareness campaigns designed to prevent drug-impaired driving and discourage underage consumption. - Local governments could not opt out of allowing marijuana businesses to operate in their area. - Delivery services would be allowed. - Serving sizes would be capped at 10 milligrams THC, with no more than 100 mg THC per package. - Existing medical cannabis operators could enter the adult-use market if they pay a $10 million licensing conversion fee. - Cannabis businesses would have to establish labor peace agreements with workers. - A legislative commission would be directed to study adding on-site consumption licenses and microbusiness cannabis event permits that would allow licensees to conduct sales at venues like farmers markets or pop-up locations. It would also investigate the possibility of the Virginia Alcoholic Beverage Control Authority becoming involved in marijuana regulations and enforcement. Newly sworn-in Gov. Abigail Spanberger (D) supports legalizing adult-use marijuana sales. “Right now is that we live in this gray space where there’s some legality to marijuana, there’s some illegality,” she said ahead of taking office. “There’s a lot of questions—a lot of confusion—and that creates real problems for Virginians who might currently have the legal ability to buy it for medicinal needs, or for those who might try to fall under the personal use.” *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* Meanwhile, Virginia lawmakers have filed other marijuana-related legislation for the 2026 session, including proposals to provide resentencing relief for people convicted of past cannabis crimes and to let terminally ill patients use medical marijuana in hospitals and other healthcare facilities. Separately, the Virginia Department of Labor and Industry recently published a new outlining workplace protections for cannabis consumers. The post Virginia Senators Approve Bill To Legalize Marijuana Sales Under New Pro-Reform Governor appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Budget-friendly marketing for the cannabis industry requires resilient distribution channels that are not dependent on platform policies. The four key strategies are: using RSS feeds for redistributable content; building resilience through consistent messaging; leveraging retailer co-distribution for amplified reach; and prioritizing audience needs over ego when shaping content. The goal is to build durable reach through consistency and versatile, owned channels. < Back 4 Restriction-Proof Ways to Get Cannabis Content Seen Oct 27, 2025 Danny Reed MG Magazine Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Digital marketing is more accessible than ever — but in cannabis, it’s also more expensive, more restricted, and more fragile. Paid campaigns can still play a role, but enforcing a real audience moat requires channels that don’t disappear when a platform changes its policy. That’s why forward-looking marketers are leaning into resilient distribution — the kind you own, co-own, or can syndicate. *1. Use RSS to turn every post into a redistributable asset* RSS is one of the most overlooked distribution tools in cannabis — not because it’s outdated, but because it was *never dependent on platform approval.* It’s instantly portable, permission-based, and re-publishable by any partner or aggregator that wants to syndicate your content. “One of the cheapest ways — basically free — a brand can distribute content is by using an RSS feed,” said Growth Skills founder and Chief Executive Officer Lavall Chichester. “Most content management systems like WordPress automatically create one for you and update it every time you publish. “Other websites can pull the RSS feed and surface your content on their site,” he added. “Brands can even monetize that through licensing.” *Takeaway:* If it lives in your RSS feed, it can live beyond your website — which means you’re not waiting for an algorithm to grant you reach. ------------------------------ *2. Build resilience through consistency, not one-off pushes* Because cannabis brands can’t rely on frequency-boosting ad auctions the way mainstream consumer packaged goods brands can, consistency is the currency of visibility. Showing up repeatedly in the same voice and values is how audiences learn to recognize and trust a message, especially when distribution volume is limited by regulation. “The trick to a successful content-distribution strategy, regardless of budget, is consistency,” said Will Read, founder and chief executive officer of CannaPlanners. “Internal perception is key. What is your mission? What are your core values, and are those understood from the top down?” Owned media — newsletters, blogs, and direct community touchpoints — give cannabis companies the staying power that social platforms can revoke at any moment. *Takeaway:* Reach may fluctuate, but consistency compounds. ------------------------------ *3. Borrow audience reach through retailer co-distribution* Retailers already have distribution — not just of product, but also of attention. When co-branded content moves through retailer channels, the brand earns amplified trust and reach without paying for platform access. “Cannabis brands can boost visibility on a budget by collaborating directly with retailers,” said Brendan McKee, co-founder and chief operating officer at Silver Therapeutics. “Spotlighting retail partners in email newsletters and posts not only promotes them, but encourages them to return the favor.” This isn’t swag tables and passive signage; it’s co-authored storytelling. And because retailers already sit inside an audience relationship, the lift is instant. *Takeaway:* Every retailer partnership can be a distribution lane when it’s framed as shared storytelling, not just shelf space. ------------------------------ *4. Let the audience, not ego, determine what travels* In a restricted marketing environment, performance isn’t about shouting louder. It’s about aligning content with what the audience actually values enough to pass along. The brands winning organic reach are the ones adapting quickly instead of defending creative sacred cows. “One piece of advice I offer clients that does not cost anything is to watch your ego and be comfortable adapting your message if it doesn’t meet the needs of the audience,” said Jim Dissett, chief communications officer at The 9th Block. “Everyone thinks their baby is the most beautiful baby in the world, but sometimes your baby just ain’t that beautiful.” *Takeaway:* Reach is earned when the message is shaped by the receiver, not the sender. ------------------------------ At the end of the day, budget-friendly marketing isn’t about cutting corners. It’s about building durable reach through consistency, versatility, and channels that can’t be taken away. When you pair audience-aligned messaging with resilient distribution, you can earn visibility that lasts. Low cost doesn’t have to mean low impact. It just requires strategy over spray-and-pray. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

The House Appropriations Committee approved a bill to block the Trump administration from rescheduling marijuana, while also continuing a separate rider protecting state medical cannabis programs from federal interference. < Back Congressional committee moves to block cannabis rescheduling (Newsletter: September 12, 2025) Sep 12, 2025 Tom Angell Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link *Trump admin to warn about marijuana & youth; GOP senator: Don’t take THC out of hemp; NH legalization hearing; TX cannabis poll* Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: *Your support makes Marijuana Moment possible…* *BREAKING*: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today. https://www.patreon.com/marijuanamoment */ TOP THINGS TO KNOW* The House Appropriations Committee approved a bill to block the Trump administration from rescheduling marijuana, while also continuing a separate rider protecting state medical cannabis programs from federal interference. The Trump administration’s Make America Healthy Again Commission is recommending the U.S. surgeon general launch an educational campaign on the impact of THC on youth health as part of a new “Make Our Children Healthy Again Strategy.” Sen. Rand Paul (R-KY) said congressional proposals to criminalize hemp products with a quantifiable amount of THC would “eradicate the hemp industry.” - “I don’t think anybody will buy those products, because, frankly, the THC– even a little bit of it—is probably what helps to make people more calm, sleep better or [have] less anxiety.” The New Hampshire House Commerce and Consumer Affairs Committee plans to move forward with a marijuana legalization bill despite opposition from Gov. Kelly Ayotte (R) and the Senate—with the sponsor saying, “Let them be the ones that are pissing off voters who care about this.” A new poll of Texas voters found that 48 percent want marijuana laws to be made less strict, 16 percent think they should stay the same and 22 percent want cannabis criminalization to be even more strict. */ FEDERAL* Rep. Greg Steube (R-FL) authored an op-ed in support of federal marijuana rescheduling. Former Sen. Kyrsten Sinema (I-AZ) discussed her experience with ibogaine. The House bill to designate psychedelic therapy centers of excellence got one new cosponsor for a total of 12. */ STATES* Ohio Gov. Mike DeWine (R) said that today’s cannabis is “much, much more potent” than “your father’s marijuana.” Texas’s agriculture commissioner praised Gov. Greg Abbott’s (R) hemp executive order. A signature gatherer for a Florida marijuana legalization campaign has been charged with alleged petition fraud and perjury. A Maryland court upheld restrictions on intoxicating hemp products. New York regulators are being sued by a chain of unlicensed marijuana shops in an effort to shut down licensed stores that were deemed too close to schools amid confusion about zoning policy. New Jersey regulators are asking local leaders to complete a survey to help them “understand how municipalities are approaching cannabis operating within their towns, such as business caps and how cannabis revenue supports municipal budgets.” Michigan regulators filed a complaint against a marijuana business over alleged violations. Colorado regulators published average market rates for retail marijuana. Oregon regulators posted quarterly data about the psilocybin services program. The Illinois Medical Cannabis Advisory Board will meet on Monday. *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* */ LOCAL* A Kansas City, Missouri City Council member is proposing legislation to allow marijuana social use lounges. The St. Cloud, Minnesota Planning Commission approved a request for a medical cannabis dispensary to add recreational marijuana sales. */ INTERNATIONAL* New Zealand lawmakers are set to debate a bill to protect people from drug charges if they are seeking help in the event of overdose. The Victoria, British Columbia, Canada City Council rejected a proposal to send a letter opposing the renewal of the province’s drug decriminalization policy. */ SCIENCE & HEALTH* A study found that “cannabidiol is associated with improved survival in pancreatic cancer and modulation of bile acids and gut microbiota.” A review concluded that “while available studies on psychedelics suggest potential benefit in cluster headache and migraine, access remains complex due to legal considerations, and additional studies are needed to confirm their effectiveness and to ensure safety before they can be recommended for use.” */ ADVOCACY, OPINION & ANALYSIS* The International Network of People Who Use Drugs, Harm Reduction International and International Drug Policy Consortium led a letter calling on the World Health Organization to continue supporting harm reduction approaches to drug policy. */ BUSINESS* Arkansas dispensaries have sold more than $193 million worth of medical cannabis products so far in 2025. *Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.* Get our daily newsletter. Email address: Leave this field empty if you're human: The post Congressional committee moves to block cannabis rescheduling (Newsletter: September 12, 2025) appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

D.C. regulators achieved a major enforcement milestone while Maryland’s Storehouse dispensary received penalties for inventory violations; Virginia is considering bills for adult-use and terminally ill patient access, and federal rescheduling could allow D.C. recreational sales. < Back D.C. Closes 100th Illegal Cannabis Business; Storehouse Fined $10K; Virginia Bills Advance Jan 13, 2026 LJ Dawson Outlaw Report Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link D.C. regulators mark a major enforcement milestone, Maryland’s Storehouse dispensary faces penalties for inventory violations, Virginia considers adult-use and terminally ill patient access bills, and federal rescheduling could open the door to D.C. recreational sales. Source < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

A Nebraska judge has dismissed a lawsuit that claimed the state’s medical cannabis program was unconstitutional because marijuana is still illegal federally. < Back Judge tosses lawsuit against Nebraska’s medical cannabis program Jun 27, 2025 Margaret Jackson MJbizDaily Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A Nebraska judge has dismissed a lawsuit alleging the state’s medical cannabis program is unconstitutional because marijuana remains federally illegal. Judge tosses lawsuit against Nebraska’s medical cannabis program is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

A federally funded study published by the AMA indicates that legalizing marijuana for medical or recreational purposes is significantly associated with reduced opioid use among cancer patients. The study, which examined prescription drug claims from 2007 to 2020, found significant reductions in opioid prescriptions after the opening of medical and recreational cannabis dispensaries. Researchers suggest that cannabis may serve as a substitute for opioids in managing cancer-related pain, and this effect was observed across different demographic groups. The findings are consistent with prior research and suggest that broader access to recreational marijuana could help address the opioid epidemic and reduce overdose deaths. < Back Legalizing Marijuana Helps Cancer Patients Reduce Opioid Use, Federally Funded Study Published By AMA Indicates Oct 17, 2025 Tom Angell Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Legalizing marijuana for medical or recreational purposes is “significantly associated with reduced opioid use among patients diagnosed with cancer,” according to a new federally funded study published by the American Medical Association (AMA). Examining prescription drug claims data from an average of more than 3 million patients annually from 2007 to 2020, the researchers found “significant reductions…in the rate of patients with cancer with opioid prescriptions, the mean daily supply, and the mean number of prescriptions per patient after medical and recreational cannabis dispensary openings.” “This study’s findings indicate cannabis may be a substitute for opioids in the management of cancer-related pain,” the paper, which was published on Friday in the Journal of the American Medical Association (JAMA) Health Forum and was funded by a grant from the National Institute on Drug Abuse, concludes. “Results of this study suggest that cannabis may serve as a substitute for opioids in managing cancer-related pain, underscoring the potential of cannabis policies to impact opioid use.” The opening of both medical and recreational marijuana dispensaries in a given state were associated with “significant reductions in all opioid outcomes,” the researchers from the University of Georgia, Indiana University and University of Chicago, wrote. “The rate of patients with cancer with opioid prescriptions changed by −41.07 per 10 000, the quarterly mean days’ supply by −2.54 days, and the mean number of prescriptions per patient by −0.099. Recreational dispensary openings were also associated with reductions in opioid outcomes, though estimated treatment effects were smaller. The rate of prescriptions changed by −20.63 per 10 000, the mean daily supply by −1.09 days supplied per prescription, and the mean number of prescriptions per patient by −0.097.” The analysis showed that reductions in opioid prescription rates and daily supply were greater when dispensaries actually opened than when states initially changed their laws to allow for medical marijuana use—”highlighting the potential impact of easier cannabis availability.” There were no significant differences opioid use as a result of cannabis reform based on age, sex, or race and ethnicity—”indicating that dispensary openings may influence opioid prescription patterns similarly across demographic subpopulations,” the paper says, suggesting that “cannabis availability may help diverse patients equally manage cancer-related pain if the observed reductions reflect substitution to cannabis.” “These findings indicate that medical or recreational cannabis laws may be significantly associated with reduced opioid use among patients diagnosed with cancer.” The researchers recommended that future studies “explore individual-level impacts, the mechanisms underlying these changes, and the longterm effects of cannabis policies on cancer pain management.” The overall results are “consistent with prior research suggesting that cannabis may serve as a substitute for opioids in managing pain,” the study says. A separate paper published this month similarly found that medical marijuana legalization is “associated with significant reductions in opioid prescribing.” In August, meanwhile, Australian researchers published a study showing that marijuana can serve as an effective substitute for opioids in pain management treatment. Another study published earlier this year in the journal Drug and Alcohol Review found that, among drug users who experience chronic pain, daily cannabis use was linked to a higher likelihood of quitting the use of opioids—especially among men. Research published late last year also found that legalizing medical cannabis appeared to significantly reduce monetary payments from opioid manufacturers to doctors who specialize in pain, with authors finding “evidence that this decrease is due to medical marijuana becoming available as a substitute” for prescription painkillers. Other recent research also showed a decline in fatal opioid overdoses in jurisdictions where marijuana was legalized for adults. That study found a “consistent negative relationship” between legalization and fatal overdoses, with more significant effects in states that legalized cannabis earlier in the opioid crisis. Authors estimated that recreational marijuana legalization “is associated with a decrease of approximately 3.5 deaths per 100,000 individuals.” “Our findings suggest that broadening recreational marijuana access could help address the opioid epidemic,” that report said. “Previous research largely indicates that marijuana (primarily for medical use) can reduce opioid prescriptions, and we find it may also successfully reduce overdose deaths.” Another recently published report into prescription opioid use in Utah following the state’s legalization of medical marijuana found that the availability of legal cannabis both reduced opioid use by patients with chronic pain and helped drive down prescription overdose deaths statewide. Overall, results of the study indicated that “cannabis has a substantial role to play in pain management and the reduction of opioid use,” it said. The post Legalizing Marijuana Helps Cancer Patients Reduce Opioid Use, Federally Funded Study Published By AMA Indicates appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Nabis acquired select assets from California distributor Humble Cannabis Solutions, expanding Nabis's operational footprint and capacity across NorCal, Central Coast, and SoCal. The deal adds approximately $13 million in assets to Nabis’ balance sheet through capital investment, distribution assets, and debt financing, and Nabis plans to integrate existing brand partners into the Nabis Marketplace. < Back Nabis Acquires Humble Cannabis Solutions’ California Assets Jan 6, 2026 Mg Magazine Newswire MG Magazine Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link *SAN FRANCISCO* — Nabis acquired select assets of Humble Cannabis Solutions, a distributor operating in California. The acquisition expands Nabis’ operational footprint and capacity across NorCal, Central Coast, and SoCal regions. The acquisition and financing add approximately $13 million in assets to Nabis’ balance sheet, according to the company, including a $4-million strategic capital investment from Humble Cannabis Solutions, $4 million in distribution assets to be integrated into Nabis’ California operations, and $5 million in debt financing. Nabis will integrate existing brand partners into the Nabis Marketplace. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

District Gas Light WEBSITE MENU REVIEWS 1738 14th Street Northwest, Washington, DC, USA About OVERALL 2.8 average rating is 2.8 out of 5 EXPERIENCE 2.9 average rating is 2.9 out of 5 QUALITY 2.7 average rating is 2.7 out of 5 SERVICE 2.8 average rating is 2.8 out of 5 SELECTION 2.8 average rating is 2.8 out of 5 PRICES 2.7 average rating is 2.7 out of 5 District Gas Light on 14th Street NW lights up the cannabis scene with its distinctive vibe. The dispensary features a gas-lamp-inspired decor, paired with a selection of premium strains and vapes. It’s a favorite for those who enjoy an atmospheric shopping experience. The staff is attentive, offering insights into the latest cannabis trends. A glowing destination for cannabis enthusiasts. Recent Reviews Check back soon Once posts are published, you’ll see them here. Trending Nearby Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... Platinum TK - Green Theory Dispensary Platinum TK is an indica-dominant hybrid from the skilled cultivators at Alt Sol that offers a robust and relaxing experience. Currently... Gelato Cake by District Cannabis - Monko DC Gelato Cake has come to be, for all intents and purposes, the flagship strain of local cultivator District Cannabis. It's an indica-domin... 1 2 3 4 5 best weed in DC (1,159) 1,159 posts DC flower (1,084) 1,084 posts DC I-71 (1,029) 1,029 posts terps (996) 996 posts DC Storefront (670) 670 posts heavy trichomes (660) 660 posts Indica Heavy Hybrid (611) 611 posts DC weed delivery (534) 534 posts starry trichomes (509) 509 posts Indica (475) 475 posts 50/50 Hybrid (421) 421 posts Sativa Dominant Hybrid (252) 252 posts Sativa (211) 211 posts Gelato (154) 154 posts DC Medical Marijuana (146) 146 posts Medical Marijuana (138) 138 posts Maryland Medical Marijuana (112) 112 posts Maryland Flower (104) 104 posts Runtz (101) 101 posts Elevated Lounge (95) 95 posts GSC (91) 91 posts alternative solutions (84) 84 posts Takoma Wellness Center (80) 80 posts The Gift Givers (78) 78 posts Maryland Recreational (75) 75 posts concentrate (74) 74 posts best weed in Maryland (74) 74 posts edibles (69) 69 posts Zkittles (69) 69 posts Alt Sol (59) 59 posts

Delaware lawmakers are seeking input from consumers and businesses ahead of the state's commercial retail marijuana market launch on August 1. The aim is to identify any issues that may need to be addressed in the next legislative session. Legal cannabis sales to adults 21 and older will begin on August 1, with existing medical marijuana operators converting to adult-use retailers. The new industry is expected to generate revenue for schools, infrastructure, and public health systems, and create opportunities for entrepreneurs. The state's Office of the Marijuana Commissioner initially projected sales to start by March, but delays occurred due to securing an FBI fingerprint background check service code. Delaware's medical marijuana program was also expanded last July, removing limitations on patient eligibility. < Back Delaware Lawmakers Seek Marijuana Consumer And Business Input Ahead Of State’s Legal Sales Launch Next Month Jul 10, 2025 Ben Adlin Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Two Delaware lawmakers who led the push to legalize marijuana are now seeking input from consumers and businesses as the state’s commercial retail market prepares to launch on August 1. The idea is to identify any hiccups that lawmakers might need to address when they return for next year’s legislative session. House Majority Whip Rep. Ed Osienski (D)—the primary sponsor of HB 1 and HB 2—and Sen. Trey Paradee (D), who also sponsored the legalization legislation, have put out a new online form for residents to share thoughts and feedback anonymously. Hosted on a Delaware Senate Democrats website, the input form says that “whether you are a customer or a retailer, we want to hear your experience with Delaware’s adult-use cannabis sale rollout.” The lawmakers said the aim of the outreach, first reported by Delaware Online, is “so that we may better advocate for any needed policy adjustments in the state legislature when we return in 2026.” Lawmakers in 2023 passed HB 1 and HB 2 to legalize and regulate adult-use cannabis—bills that then-Gov. John Carney (D) allowed to become law without his signature. Regulators last month announced that legal cannabis sales to people 21 and older would begin on August 1. “The start of legal adult-use marijuana sales reflects the tireless efforts of our regulatory team and our strong partnerships with state agencies, industry stakeholders, and community leaders,” Marijuana Commissioner Joshua Sanderlin said in a press release, adding that the state’s focus “is on building a safe, equitable, and accountable marijuana market that delivers real benefits to Delawareans.” Offering products will be all seven of Delaware’s existing medical marijuana operators, which have since converted to adult-use retailers. There are at least 13 locations across the state expected to be open for recreational sales next month. Current Gov. Matt Meyer (D) has cheered the development, recently saying that “Delaware has taken a major step forward by launching a legal adult-use cannabis market that prioritizes equity, safety, and accountability.” “This new industry will generate critical revenue to strengthen our schools, infrastructure, and public health systems, while creating real opportunities for entrepreneurs,” the governor said. “This revenue also gives us a powerful tool to invest in the communities most impacted by the war on drugs, addressing past wrongs and ensuring that the benefits of this new market reach every corner of our state.” The state’s Office of the Marijuana Commissioner (OCM) initially projected that recreational sales would start by March, but complications related to securing an FBI fingerprint background check service code delayed the implementation. Lawmakers passed a bill in April to resolve the issue, and the FBI subsequently issued the code that the stat’s marijuana law requires. Late last year, OMC held a series of licensing lotteries for cannabis business to start serving adult consumers. A total of 125 licenses will ultimately be issued, including 30 retailers, 60 cultivators, 30 manufacturers and five testing labs. Last year, regulators also detailed what portion of each category is reserved for social equity applicants, microbusinesses and general open licenses. Regulators have also been rolling out a series of proposed regulations to stand up the forthcoming adult-use cannabis industry. Meanwhile, Carney raised eyebrows in January after making a questionable claim that “nobody” wants cannabis shops in their neighborhoods, even if there’s consensus that criminalization doesn’t work. The then-governor last year signed several additional marijuana bills into law, including measures that would allow existing medical cannabis businesses in the state to begin recreational sales on an expedited basis, transfer regulatory authority for the medical program and make technical changes to marijuana statutes. The dual licensing legislation is meant to allow recreational sales to begin months earlier than planned, though critics say the legislation would give an unfair market advantage to larger, more dominant businesses already operating in multiple states. In October, Carney also gave final approval to legislation to enact state-level protections for banks that provide services to licensed marijuana businesses. Delaware’s medical marijuana program is also being significantly expanded under a law that officially took effect last July. The policy change removes limitations for patient eligibility based on a specific set of qualifying health conditions. Instead, doctors will be able to issue cannabis recommendations for any condition they see fit. The law also allows patients over the age of 65 to self-certify for medical cannabis access without the need for a doctor’s recommendation. *Photo courtesy of Chris Wallis // Side Pocket Images.* The post Delaware Lawmakers Seek Marijuana Consumer And Business Input Ahead Of State’s Legal Sales Launch Next Month appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

At Toker's Guide we're helping people find the best weed in Washington D.C., Virginia, and Maryland with our connoisseur reviews. Every day our team of experts reach out to local marijuana dispensaries, marijuana delivery services, and cannabis cultivators to identify the best weed currently available. Then we report the top options we find to our audience in the form of reviews and photos. Essentially, you can use our guide and the pages within to locate the best marijuana around in real time. Find the BEST weed in Washington DC With Reviews from Local Connoisseurs LEARN MORE A WORD FROM OUR SPONSORS: Let Us Guide You At Toker's Guide we're helping people find the best weed in Washington D.C., Virginia, and Maryland with our connoisseur reviews. Every day our team of experts reach out to local marijuana dispensaries, marijuana delivery services, and cannabis cultivators to identify the best weed currently available. Then we report the top options we find to our audience in the form of reviews and photos. Essentially, you can use our guide and the pages within to locate the best marijuana around in real time. Happy Toking! 😮💨 Featured Product Reviews View Now DC Marijuana Delivery & Services View Now Maryland Marijuana Dispensaries View Now DC Marijuana Dispensaries View Now How to Buy Weed in Washington DC View Now Virginia Marijuana Dispensaries View Now Let Us Guide You Featured Reviews A WORD FROM OUR SPONSORS: Featured REVIEWS DISPENSARIES DELIVERY ALL REVIEWS Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Maryland Terps 3 days ago 3 min read Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... Elle Weeds 4 days ago 2 min read Gary Payton | Cookies x Alt Sol | Adegoke Dispensary DC Gary Payton, the cannabis strain, much like the legendary NBA player it's named after, is all about precision and impact. Just as the Hal... Toker's Guide Jan 16 2 min read Platinum TK - Green Theory Dispensary Platinum TK is an indica-dominant hybrid from the skilled cultivators at Alt Sol that offers a robust and relaxing experience. Currently... Elle Weeds Jan 16 2 min read Bubble Bath - Story Dispensary (Hyattsville, MD) After picking up a slice of this Fade Co. Bubble Bath from Story Dispensary in Hyattsville, Maryland, I decided to swing by a friend’s place a couple miles away. Nestled in one of the town’s tree-lined streets where bungalows hum with creative energy and holiday lights twinkle, her cute abode is always such a cozy place to hang out. Hyattsville’s artsy pulse - evident in the murals splashing color across Route 1 and the indie vibe of local spots like Vigilante Coffee - made t Elle Weeds Jan 15 2 min read Gelato Cake by District Cannabis - Monko DC Gelato Cake has come to be, for all intents and purposes, the flagship strain of local cultivator District Cannabis. It's an indica-domin... Toker's Guide Jan 7 2 min read Cookies & Alt Sol "Blue Raz" Strain Review - Takoma Wellness Center Blue Raz, originally bred by Grandiflora and cultivated to perfection by Alt Sol, is now gracing the shelves at Takoma Wellness Center in... Toker's Guide Jan 7 2 min read Triple Burger by Alt Sol - Green Theory Recently harvested by DC craft cultivator Alt Sol, this phenomenal Triple Burger just dropped at Washington DC medical marijuana dispensa... Toker's Guide Jan 7 3 min read Snoop Dogg OG by SunMed - Columbia Care Dispensary (Chevy Chase, Maryland) This batch of Snoop Dogg OG, named after the rap legend and cannabis enthusiast Snoop Dogg himself, is the "shizzle". Currently available... Maryland Terps Dec 19, 2025 2 min read Fuel Biscuits by Alt Sol - Green Theory DC This recent batch of Fuel Biscuits, cultivated by Alt Sol and available at Green Theory in Washington, DC, is an indica-dominant hybrid t... Toker's Guide Dec 18, 2025 2 min read 1 2 3 4 5 best weed in DC (1,159) 1,159 posts DC flower (1,084) 1,084 posts DC I-71 (1,029) 1,029 posts terps (996) 996 posts DC Storefront (670) 670 posts heavy trichomes (660) 660 posts Indica Heavy Hybrid (611) 611 posts DC weed delivery (534) 534 posts starry trichomes (509) 509 posts Indica (475) 475 posts 50/50 Hybrid (421) 421 posts Sativa Dominant Hybrid (252) 252 posts Sativa (211) 211 posts Gelato (154) 154 posts DC Medical Marijuana (146) 146 posts Medical Marijuana (138) 138 posts Maryland Medical Marijuana (112) 112 posts Maryland Flower (104) 104 posts Runtz (101) 101 posts Elevated Lounge (95) 95 posts GSC (91) 91 posts alternative solutions (84) 84 posts Takoma Wellness Center (80) 80 posts The Gift Givers (78) 78 posts

U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. is committed to expanding research on psychedelic therapy, aiming to provide legal access for military veterans within 12 months. Clinical trials are underway, and preliminary results are encouraging. Congress has mandated clinical trials for active-duty military veterans. Bipartisan lawmakers are seeking ways to provide access to psychedelic medicine for veterans. The VA is also funding studies on MDMA-assisted therapy. < Back RFK Says Trump Administration Could Provide Psychedelic Therapy To Military Veterans ‘Within 12 Months’ Jun 24, 2025 Staff Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. says his agency is “absolutely committed” to expanding research on the benefits of psychedelic therapy and, alongside of the head of the Food and Drug Administration (FDA), is aiming to provide legal access to such substances for military veterans “within 12 months.” He also said that he speaks with U.S. Department of Veterans Affairs (VA) Secretary Doug Collins about psychedelics policy issues “all the time.” At a hearing before the House Energy & Commerce Committee on Tuesday, Rep. Dan Crenshaw (R-TX) asked Kennedy about plans at HHS to advance psychedelics studies, stressing the need to make the novel therapies available to people with serious mental health conditions such as post-traumatic stress disorder and depression. “We are launching clinical trials now on that at FDA,” Kennedy said, adding that there are currently “11 clinical trials at the VA going on at this point—particularly for our service members and retired service members.” “It’s critically important that we make sure that the science on this is solid, and the preliminary results are very, very encouraging and it’s something that we want to pursue,” he said, adding that he’s spoke with FDA Commissioner Marty Makary, who told him “we don’t want to wait two years to get this done.” “These are people who badly need some kind of therapy. Nothing else is working for them,” Kennedy said. “This line of therapeutics has tremendous advantage, if given in a clinical setting, and we are working very hard to make sure that that happens within 12 months.” After Crenshaw brought up the fact that Congress has passed legislation mandating that the Department of Defense (DOD) conduct clinical trials into psychedelics for active duty military veterans, the health secretary also noted that he’s “brought on personnel to liaison directly with VA,” and that he speaks with Collins about it “all the time.” “It’s something that both of us are deeply interested in,” he said. To that end, Collins also disclosed in April that he had an “eye-opening” talk with Kennedy about the therapeutic potential of psychedelic medicine. And he said he’s open to the idea of having the government provide vouchers to cover the costs of psychedelic therapy for veterans who receive services outside of VA as Congress considers pathways for access. Collins also recently visited a facility conducting research on psychedelics, and he reiterated that it’s his “promise” to advance research into the therapeutic potential of the substances—even if that might take certain policy changes within the department and with congressional support. The secretary’s visit to the psychedelics research center came about a month after the VA secretary met with a military veteran who’s become an advocate for psilocybin access to discuss the therapeutic potential of psychedelic medicine for the veteran community. Collins also briefly raised the issue in a Cabinet meeting with President Donald Trump in April. Psychedelic therapies show real promise for veterans and others battling trauma. We’re accelerating clinical trials at @US_FDA with urgency—and working to ensure safe, science-based access within 12 months. Some therapies can’t wait. pic.twitter.com/GDvccSleEJ — Secretary Kennedy (@SecKennedy) June 24, 2025 Meanwhile last month, bipartisan congressional lawmakers asked the VA head to meet with them to discuss ways to provide access to psychedelic medicine for military veterans. In a letter sent to Collins, Reps. Lou Correa (D-CA) and Jack Bergman (R-MI)—co-chairs of the Congressional Psychedelic Advancing Therapies (PATH) Caucus—said they were “encouraged by your recent remarks about the importance of pursuing research into psychedelic treatments and other alternative treatments to improve Veterans’ care.” Correa and Bergman separately introduced a bill in April to provide $30 million in funding annually to establish psychedelics-focused “centers for excellence” at VA facilities, where veterans could receive novel treatment involving substances like psilocybin, MDMA and ibogaine. Bergman has also expressed optimism about the prospects of advancing psychedelics reform under Trump, arguing that the administration’s efforts to cut spending and the federal workforce will give agencies “spines” to tackle such complex issues. Kennedy, for his part, also said in April that he had a “wonderful experience” with LSD at 15 years old, which he took because he thought he’d be able to see dinosaurs, as portrayed in a comic book he was a fan of. Last October, Kennedy specifically criticized FDA under the prior administration over the agency’s “suppression of psychedelics” and a laundry list of other issues that he said amounted to a “war on public health” that would end under the Trump administration. *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* In December, VA separately announced that it’s providing $1.5 million in funding to study the efficacy of MDMA-assisted therapy for veterans with PTSD and alcohol use disorder (AUD). Last year, VA’s Yehuda also touted an initial study the agency funded that produced “stunning and robust results” from its first-ever clinical trial into MDMA therapy. In January, former VA Under Secretary for Health Shereef Elnahal said that it was “very encouraging” that Trump’s pick to have Kennedy lead HHS has supported psychedelics reform. And he hoped to work with him on the issue if he stayed on for the next administration, but that didn’t pan out. DEA Judge Sides With Agency On Proposal To Ban Two Psychedelics Despite Challenge From Scientific Researchers The post RFK Says Trump Administration Could Provide Psychedelic Therapy To Military Veterans ‘Within 12 Months’ appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5